Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Bespoke Extracts Announces Uplisting to OTCQB Exchange


Posted on: 24 Jul 18

SUNNY ISLES, Fla., July 24, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTCQB:BSPK), producer of high quality, great tasting, hemp-derived CBD extract products, today announced that its common stock has been approved for uplisting to the OTCQB Venture Market Place, effective immediately.

The OTCQB is considered by the U.S. Securities and Exchange Commission (SEC) as an “established public market” for the purpose of determining the public market price when registering securities for resale with the SEC.  The OTC Pink is not considered as such and most broker-dealers will not trade or recommend OTC Pink stocks.  Because the OTCQB dramatically increases transparency, reporting standards, management certification and compliance requirements, the majority of broker-dealers trade stocks on the OTCQB.  Historically, this has resulted in improved liquidity and awareness for companies that ascend to the OTCQB tier.  The OTCQB is a venture market designed for early-stage and developing US and international companies. To be eligible, companies must be current in their reporting and undergo an annual verification and management certification process. To learn more, visit OTCQB.

“We are very pleased to be trading on the OTCQB as it will provide our shareholders and potential new investors with greater transparency and liquidity in our common stock.  Moreover, we believe that trading on this established public market will help to generate enhanced exposure of our Company among institutional investors who typically would not invest in Pink Sheet companies,” noted Marc Yahr, Bespoke Extracts CEO.

About Bespoke Extracts, Inc.

Bespoke Extracts, Inc. was formed in early 2017 to introduce a proprietary line of premium quality, all-natural cannabidiol (CBD) products in the form of tinctures and capsules for the nutraceutical and veterinary markets. Produced using pure, all natural, zero-THC phytocannabinoid-rich (“PCR”) hemp-derived CBD, our products are marketed as dietary supplements and distributed through our direct-to-consumers ecommerce store, found at www.bespokeextracts.com.

For more information, please contact:

Bespoke Extracts, Inc.
Phone: 888-575-6738
Email: info@BespokeCBD.com
Web:  www.BespokeCBD.COM

GlobeNewswire
globenewswire.com

Last updated on: 24/07/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.